The company earned U.S. Patent No. US 11,771,482 B2: Implants for tissue fixaton and fusion.
“Our patent position affords us the ability to freely develop a broad portfolio of patent protected trabecular fixation devices for all orthopedic applications, while at the same time confidently protect our market position both present and future,” President and CEO Randy Roof said in the release. “Our first such 510(k) cleared spinal system, T-FIX 3DSI Joint Fusion System, was introduced to the market in late spring of this year and it has quickly positioned Cutting Edge Spine as a front-runner in the fast growing SI fixation market.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
